Adenovirus-polylysine-DNA complexes were evaluated for their capacity to accomplish direct in vivo gene transfer to airway epithelium employing a rodent model. Binary complexes containing transferrin or adenovirus, or combination complexes containing both transferrin and adenovirus, were evaluated. The highest in vitro gene transfer efficiency in primary cultures of airway epithelial cells was accomplished by the combination complexes. This result was paralleled in vivo. Transient gene expression of up to 1 week was observed with localization of the transduced cells to the region of the small airways. These results establish the feasibility of this type of approach for gene therapy applications.
INTRODUCTION
GENETIC MODIFICATION of airway epithelium offers a potential therapeutic strategy for a variety of inherited and acquired pulmonary disorders. Because it has not yet been feasible to reimplant airway epithelial cells modified ex vivo, delivery of the heterologous genetic material must occur by direct in vivo transducfion ofthe target cell in situ. The access to airway epithelium offered by the anatomy of the tracheobronchial tree suggests that in vivo gene transfer be accomplished by direct delivery via the airway route. The low proliferative rate ofthe airway epithelium (Bolduc and Reid, 1976) requires that candidate vectors be capable of gene transfer to a nonreplicating cellular target (Engelhardt and Wilson, 1992) .
Foreign gene expression in airway epithelium has been demonstrated after direct in vivo delivery employing lipofection (Brigham et al., 1989; Hazinski et al., 1991; Yoshimura et al., 1992) and recombinant adenoviruses (Rosenfeld et al., 1991 . For practical application in therapeutic protocols, however, lipofection may be limited by its cellular toxicity (Feigner etal., 1987; Malone etal., 1989) . In addition, this vector lacks cell-specific tropism. Nonspecific delivery after topical administration via the airway route may be potentially deleterious in settings where cell-specific gene expression is required. Direct in vivo delivery employing a recombinant derivative of the respiratory tropic adenovirus offers a more efficient vector system . Potential safety hazards, however, derive from the obligatory codelivery of gene elements of the parent virus. In this regard, recombinant adenovunis vectors containing deletions of the early gene regions ElA/E IB have been shown to be associated with expression of viral late genes as well as limited viral replication (Nevins, 1981; Gaynor and Berk, 1983; Imperiale eta/., 1984) .
As an altemative to these approaches, we have explored the utility of using adenovirus-polylysine-DNA complexes to accomplish direct in vivo gene delivery to the respiratory epithelium. This vector system offers several potential advantages for The University of North Carolina Departments of Medicine and 'Pediatrics, and the ^Research Institute for Molecular Pathology, Vienna, Austria.
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in vivo applications (Wu and Wu, 1988; Wagner et al., 1990; Zenke et al., 1990; Cotton et al., 1991) . These advantages include a design plasticity that permits the potential to accomplish cell-specific targeting. As entry is via a cellular intemalization pathway, complexes may be administered on a continuous or repetitive basis. In addition, adenovims-polylysine-DNA complexes have been constmcted that possess extremely high in vitro gene transfer efficiencies.
We have previously shown that gene transfer efficiency via the receptor-mediated pathway can be dramatically improved by incorporation of an adenovims moiety into the design of the complex Wagner et al., 1992) . In this configuration, the adenovims functions to allow escape of the conjugate-DNA complex from endosomes. Because this effect of adenovims is mediated by viral capsid proteins and is independent of viral gene expression (Pastan et al., 1986) , it is possible to take measures to inactivate the adenoviral genome. Thus, a combination of genomic deletions and psoralen plus UV-irradiation can be used to minimize the potential safety hazards deriving from the presence of viral gene elements (Cotten era/., 1992) .
In the present work, we show that we can accomplish direct in vivo gene transfer to the respiratory epithelium in a rodent model using adenovims-polylysine-DNA complexes. This establishes the feasibility of this approach as a method to accomplish transient gene expression in the respiratory epithelium. The capacity to achieve genetic modification of the airway epithelial cells in situ offers a potential strategy to accomplish gene therapy for disorders afflicting the airway epithelium.
Gene transfer to primary cultures of cotton rat airway epithelial cells Cultures of cotton rat airway epithelial cells were prepared by described methods (Van Scott et al., 1986) . Dissociated cells were harvested, washed three times with F12-7X media, and plated at a density of 5.0 x 10^ cells/dish in 3-cm tissue culture dishes. Cells were maintained in F12-7X media and utilized for gene transfer experiments when they achieved 50-75% confluency. This usually required 2-3 days. For gene transfer experiments, the formed complexes were delivered directly to the cells and incubated for 24 hr. Complexes evaluated included human transferrin-polylysine (hTfpL), adenovirus-polylysine (AdpL), and human transferrin-adenovims-polylysine (hTfpL/ AdpL). After incubation, cells were either lysed and evaluated for luciferase gene expression by described methods (Brasier et al., 1989) or stained for P-galactosidase expression utilizing X-gal (MacGregor and Caskey, 1989) . For luciferase assays indicating net gene expression, epithelial cells in primary culture were treated with complexes containing the reporter plasmid DNA pCLuc4 (6.0 |jig). For p-galactosidase assays indicating in situ gene expression, cells were treated with complexes containing the reporter plasmid DNA pCMVp (6.0 p-g).
Gene transfer to cotton rat airway epithelium in vivo Formed complexes were delivered to cotton rats via the intratracheal route. For analysis of relative in vivo transfer effi-
MATERIALS AND METHODS

Preparation of gene transfer vectors
Human transferrin-polylysine-DNA complexes (hTfpL) were prepared by combination of (8.0 |xg) human transferrinpolylysine (Serva Biochemical) in 150 p.1 of NaCl 150 mM/ HEPES 20 mM pH 7.3 (HBS) plus 6.0 |jig of plasmid DNA in 350 p-I of HBS followed by 30 min incubation at room temperature. The adenovims-component complexes were of two types: binary complexes that contained adenovims linked to polylysine-DNA (AdpL) and combination complexes that contained adenovims plus human transferrin linked to polylysine-DNA (hTfpL/AdpL). The adenoviral component complexes were prepared utilizing the chimeric adenovirus P202 linked to polylysine by an antibody bridge or the replication-incompetent adenovims rf/312 linked to polylysine by a chemical bridge consisting of biotin and streptavidin (bAd) . In the latter instance, the vims was further inactivated by treatment with psoralen plus UV irradiation prior to complex formation. The reporter plasmid DNA pCLuc4 was used for assays of net gene expression. This plasmid contains the firefly luciferase gene under the transcriptional control ofthe cytomegalovims (CMV) enhancer/early promoter. The reporter plasmid DNA pCMVp was used for assays of localized gene expression. This plasmid contains the bacterial lacZ (P-galactosidase expressing) gene under the transcription control of the CMV enhancer/early promoter. ciency, the evaluated complexes included human transferrinpolylysine (hTfpL), adenovims-polylysine (AdpL), and human transferrin-adenovims-polylysine (hTfpL/AdpL). These complexes contained the reporter plasmid DNA pCLuc4. For histologic localization of in vivo gene transfer, the human transferrin-adenovims-polylysine complexes (hTfpL/AdpL) contained the lacZ reporter plasmid DNA pCMVp. For evaluation of temporal pattem of in vivo gene expression, the complex utilized was the human transferrin-adenovims-polylysine complex containing replication-defective adenoviras rf/312 that had been inactivated by psoralen plus UV-irradiation (hTfpL/ bAdpL). These complexes contained the reporter plasmid DNA pCLuc4. Animals were anesthetized with methoxyflurane. After a vertical incision in the ventral aspect of the neck, the trachea was isolated by blunt dissection. With the animal inclined at a 45° angle, the complexes (250-300 p,l; 3.0 p,g of plasmid DNA) were injected directiy into the trachea under direct visualization. At indicated times post-injection, the animals were sacrificed by COj inhalation and trachea and lung were harvested en bloc after perfusion of pulmonary vessels in situ with cold phosphate-buffered saline (PBS). For luciferase assays, the lung blocks were homogenized in extraction buffer, and lysates were standardized for total protein content and evaluated for luciferase gene expression as described (Brasier etal., 1989) . For the p-galactosidase assays, frozen sections of intact unperfused lung were prepared and stained with X-gal as described (MacGregor and Caskey, 1989) .
RESULTS
Background hTfpL
AdpL hTfpL/ AdpL   FIG. 3 . Relative levels of net gene transfer to cotton rat airway epithelium in vivo. The firefly luciferase reporter gene containing plasmid pCLuc4 was used to form conjugate-DNA complexes, which were delivered to cotton rats via injection by the intratracheal route. Lungs were harvested and lysates were evaluated for luciferase gene expression after 24 hr. Vector species included human transferrin-polylysine-DNA complexes (hTfpL), adenovims-polylysine-DNA complexes (AdpL), and human transferrin-adenovuus-polylysine-DNA complexes (hTfpL/AdpL). Background indicates evaluation of lungs irom untreated animals. Ordinate represents luciferase gene expression as light units per 1250 p,g total protein derived from lung lysates. Experiments were performed three to four times each and results are expressed as mean ± SEM.
Gene transfer to cotton rat airway epithelial cells in primary culture via receptor-mediated delivery
The cotton rat (Sigmodon hispidus) has been shown to be an animal model of human adenoviral lung disease (Pacini et al., 1984) and therefore was employed as a target for gene transfer to respiratory epithelial cells employing adenovims-polylysine-DNA complexes. The gene transfer efficiency of the various conjugate designs was initially evaluated by transfecting primary cultures of cotton rat airway epithelial cells with a firefly luciferase reporter plasmid pCLuc4 (Fig. 1) . Comparison was made among simple binary complexes that intemalize through the transfenin pathway (hTfpL), binary adeno viralcomponent complexes intemalizing via the adenoviral pathway (AdpL), and combination complexes possessing both transferrin and adenoviral domains and thus the capacity to intemalize by both pathways (hTfpL/AdpL). In this analysis, the cotton rat airway epithelium in primary culture showed only a very low level of luciferase gene expression employing the hTfpL complexes. This is consistent with the fact that this conjugate species may be entrapped within cellular endosomes, owing to the lack of a specific cell vesicle escape mechanism (Curiel et al., 1991 Wagner era/., 1992) . The adenovims-component binary complexes (AdpL) exhibited significantly greater gene expression. This was further augmented by the inclusion of a second ligand domain in the combination configuration (hTfpL/ AdpL). To determine if the relative levels of net gene expression correlated with transduction frequency, we next evaluated the percentage of cells transduced with the various complex species employing the lacZ histologic reporter plasmid pCMVp, which encodes the bacterial p-galactosidase gene (Fig. 2) . In this analysis, it could be seen that the relative levels of net gene expression observed in the luciferase assay reflected the relative numbers of cells transduced. Thus, the hTfpL-modified airway epithelium in primary culture exhibited <1% transduction frequency, the AdpL complexes on the order of 20-30%, and the hTfpL/AdpL combination complexes greater than 50% modified cells.
Gene transfer to cotton rat airway epithelia in vivo via receptor-mediated delivery
The various complex species were next delivered to the airway epithelium ofthe rodent model by the airway route. Initial evaluation determined the relative in vivo gene transfer efficiency of the complexes employing the luciferase reporter (Fig.  3) . In this analysis, the relative efficiency of the complexes in vivo paralleled the finding in the analysis of primary cultures of airway epithelial cells. Thus, the hTfpL complexes mediated levels of luciferase gene expression in lung extract only slightiy above levels observed in unmodified lung. Higher levels were achieved by the AdpL complexes and the highest levels were achieved by the hTfpL/AdpL combination complexes. Whereas the magnitude of net gene expression observed in vivo was of a lower order than that observed for the in vitro experiments, no conclusions may be drawn as relates to relative efficiency in The firefly luciferase reporter gene containing plasmid pCLuc4 was used to form conjugate-DNA complexes which were delivered to cotton rats via injection by the intratracheal route. The complexes (hTfpL/ bAdpL) were formed with human transferrin-polylysine and adenovirus that had been inactivated by genomic deletion and treatment with psoralen plus UV-irradiation. Lungs were harvested and lysates evaluated for luciferase gene expression at various time points post-injection. Ordinate represents luciferase gene expression as light units per 1,250 p-g total protein derived from lung lysates. Experiments were performed three to four times each and results were expressed as mean ± SEM.
these two contexts. For the in vitro experiments, all of the cells harvested for analysis were accessible to conjugate-mediated gene transfer. For the in vivo experiments, the respiratory epithelium accessible to transduction represented only a minor fraction of the harvested lung material evaluated for net gene expression. We next evaluated in vivo transduction efficiency employing the lacZ histologic reporter (Fig. 4) . This analysis was limited to the hTfpL/AdpL complex species, which exhibited the highest net in vivo gene transfer. Evaluation of histologic lung sections of animals treated in this manner demonstrated patchy areas of p-galactosidase activity containing multiple marked cells. As a control, no P-galactosidase activity could be detected in animals transduced with the hTfpL/AdpL complexes containing an irrelevant plasmid DNA. These positive regions were localized to the bronchioles and distal airway region. Specific airway epithelial subsets modified could not be determined in this assay.
The time course of heterologous gene expression in the airway epithelium was evaluated by using the luciferase reporter gene in combination with the hTfpL/bAdpL combination complexes (Fig. 5) . For this analysis, the adenovims had been inactivated by a combination of gene deletion and treatment with psoralen plus UV-irradiation . This modification allows prolonged in vitro expression consequent to minimized adenoviral replication and/or gene expression. Maximum gene expression was noted at 24 hr post-administration. There was a rapid decrease of net gene expression such that levels diminished to background by day 7.
DISCUSSION
In this preliminary report, we demonstrate the feasibility of accomplishing heterologous gene expression to the respiratory epithelium in situ employing adenoviras-polylysine-DNA complexes. Whereas in vivo transduction of airway epithelium has been obtained utilizing other vector systems, adenovimspolylysine-DNA complexes offer several potential advantages for this application. Practical advantages derive from the fact that this vector system transports heterologous DNA bound to the viral capsid exterior rather than incorporated into the parent vims genome as is the case for recombinant adenoviral vectors (Berkner, 1988; Curiel ef a/., 1992) . Thus, theamountof DNA that can be transported is not limited by packaging constraints of the recombinant viral system. Whereas the upper size limit of DNA transportable by recombinant adenoviral vectors is on the order of 6-8 kb (Berkner, 1988) , up to 48 kb of DNA has been transferred utilizing the adenovims-polylysine-DNA complexes . In addition, the DNA is incorporated into the complexes in a sequence-independent manner. Gene constmcts transferred are thus not restricted to the context of viral regulatory controls.
Potential advantages are also offered from a safety standpoint. The production of recombinant adenoviral vectors requires maintenance ofthe functional integrity ofthe parent viral genome, since the heterologous sequences are incorporated therein. Despite genetic maneuvers to limit the replicative capacity ofthe vectors, the ElA/E IB deletion mutants are associated with late viral gene expression and detectable viral replicative capacity (Nevins, 1981; Gaynor and Berk, 1983; Imperiale et al., 1984; Gregory et al., 1992) . In the configuration of the adenovims-polylysine-DNA complexes, the entry mechanism of the viras is exploited in a selective manner whereby viral gene elements are not an essential feature . Thus, it is feasible to inactivate the parent viral genome by using a combination of mechanisms, including viral gene deletions and psoralen plus UV irtadiation, as we have done here. By extending this strategy of vector design, it is theoretically possible that viral gene elements may be ultimately eliminated, thereby creating an even safer vector.
The marked plasticity of molecular conjugate design allowed the derivation of a vector with optimized in vivo gene transfer efficiency. The low gene transfer capacity of the hTfpL complexes in vitro and in vivo is consistent with the fact that this species may be entrapped within the cell vesicle system after intemalization consequent to the lack of a specific endosome escape mechanism (Curiel et al., 1991 Wagner et al., 1992) . The AdpL complexes make use of the adenovims as both ligand domain and endosomolysis principle. These complexes could thus be intemalized via adenoviral receptors and escape cell vesicle entrapment by virtue of adenovims-mediated endosomolysis. This fact was reflected in the significantly augmented gene transfer capacity of these complexes. The addition of a second ligand to the complexes in the hTfpL/AdpL configuration allowed even greater gene transfer to occur both in vitro and in vivo. The fact that these complexes contain two potential ligand domains allows their intemalization by both of these pathways. Whereas no direct comparison is made in this study between the in vivo gene transfer efficiency of recombinant adenoviral vectors and adenovims-polylysine-DNA complexes, it is noteworthy that in the case of the adenovimspolylysine-DNA complexes the conjugate design may be modified such that it possesses the capacity to intemalize both by the adenoviral as well as altemate internalization pathways. A more direct comparison can be made to lipofectin whereby gene expression levels obtained after delivery employing the human transferrin-adenovirus polylysine-DNA complexes were two orders of magnitude greater than levels observed in a similar protocol utilizing the cationic liposomes ) (data not shown).
The detectable in vivo gene expression mediated by the adenovims-polylysine DNA complexes was of a transient nature. This closely parallels the expression pattem noted after lipofectin-mediated in vivo gene transfer to the respiratory epithelium (Hazinski et al., 1991) . This result is not unanticipated because the delivered DNA would be present as a plasmid episome lacking replicative or integrative capacity (Wilson etal., 1992) . In the present design, the conjugate system lacks a mechanism to mediate integration and thus the stable transduction frequency would be expected to be low. Alternatively, attrition of the modified cells could explain the extinction of gene transfer in the lung. The fate of individual modified cells was not addressed in this study and thus the possibility of vector-associated cell toxicity could not be excluded.
Transient genetic modification of the airway epithelium may be potentially beneficial in certain therapeutic contexts. For gene therapy of inherited disorders afflicting respiratory epithelium such as cystic fibrosis (Boat et al., 1989) , however, permanent correction of cellular targets is desirable. Application of transient expression systems such as molecular conjugates or recombinant adenovimses to achieve long-term correction would thus require repetitive dosing. It is unclear whether this would be feasible given the potential immunologic sequelae that may derive from this type of treatment. Thus, the incorporation of an integration mechanism within the design of the conjugate vector would likely enhance its utility for therapeutic genetic modification of airway epithelium as well as for a variety of other genetic correction applications.
